Gregory S. Martini insider trades
Open-market stock purchases and sales by Gregory S. Martini, Chief Financial Officer at Kyverna Therapeutics, Inc, from SEC Form 4 filings since Jan 27, 2025.
Open-market stock purchases and sales by Gregory S. Martini, Chief Financial Officer at Kyverna Therapeutics, Inc, from SEC Form 4 filings since Jan 27, 2025.